Albuterol

Asmavent® CFC-free Inhaler is indicated in the management of asthma, for the relief of asthma symptoms such as wheezing and shortness of breath, on an as required basis. Asmavent® CFC-free Inhaler should be used to relieve symptoms when they occur and to prevent symptoms in those circumstances recognised by the patient to precipitate an asthma attack, for example before exercise or unavoidable allergen exposure.

Asmavent® CFC-free Inhaler can be used for the relief of symptoms in mild, moderate or severe asthma providing that reliance on the inhaler does not delay the introduction and use of regular inhaled corticosteroid therapy. Asmavent® CFC-free Inhaler may also be used in the treatment of the reversible component of airways obstruction.

1 INDICATIONS AND USAGE Albuterol Sulfate HFA is a beta 2 -adrenergic agonist indicated for: Treatment or prevention of bronchospasm in adult and pediatric patients aged 4 years and older with reversible obstructive airway disease.

1 ) Prevention of exercise-induced bronchospasm in adult and pediatric patients aged 4 years and older. 1 Bronchospasm Albuterol Sulfate HFA Inhalation Aerosol is indicated for the treatment or prevention of bronchospasm in adult and pediatric patients aged 4 years and older with reversible obstructive airway disease.

2 Exercise-Induced Bronchospasm Albuterol Sulfate HFA is indicated for the prevention of exercise-induced bronchospasm in adult and pediatric patients aged 4 years and older.

V. V. Infusion / 1000 mcg/mL sodium chloride, sulphuric acid, and/or sodium hydroxide, water for injection For a complete listing see Dosage Forms, Composition and Packaging section. V. infusion solution is indicated in adults (> 18 years of age) for: the relief of severe bronchospasm associated with acute exacerbations of chronic bronchitis and bronchial asthma, the treatment of status asthmaticus.

In many patients, VENTOLIN® infusion solution will be no more effective, and likely less well tolerated, than VENTOLIN® HFA inhalation aerosol or VENTOLIN® respirator solution. However, patients who are severely ill with airway inflammation and mucus plugging may respond well to parenteral salbutamol after failing to benefit from the inhaled drug.

This product should be administered under the supervision of a qualified health professional who is experienced in the use of parenteral preparations and in the management of asthma. Appropriate management of therapy and complications is only possible when adequate diagnostic and treatment facilities are readily available.